Novo Nordisk
NVO
NVO
469 hedge funds and large institutions have $9.21B invested in Novo Nordisk in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 163 increasing their positions, 175 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
7% less repeat investments, than reductions
Existing positions increased: 163 | Existing positions reduced: 175
4% less funds holding in top 10
Funds holding in top 10: 26 → 25 (-1)
41% less call options, than puts
Call options by funds: $5.37M | Put options by funds: $9.13M
Holders
469
Holding in Top 10
25
Calls
$5.37M
Puts
$9.13M
Top Buyers
| 1 | +$116M | |
| 2 | +$90.2M | |
| 3 | +$60M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$23.8M |
| 5 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$18.1M |
Top Sellers
| 1 | -$41.9M | |
| 2 | -$40.3M | |
| 3 | -$35.1M | |
| 4 |
TIM
Thornburg Investment Management
Santa Fe,
New Mexico
|
-$24.8M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
-$17.3M |